97 related articles for article (PubMed ID: 3935273)
1. Brain angiotensin II and III binding and dipsogenicity in the rabbit.
Wright JW; Sullivan MJ; Petersen EP; Harding JW
Brain Res; 1985 Dec; 358(1-2):376-9. PubMed ID: 3935273
[TBL] [Abstract][Full Text] [Related]
2. Central angiotensin III-induced dipsogenicity in rats and gerbils.
Wright JW; Morseth S; Mana MJ; LaCrosse E; Petersen EP; Harding JW
Brain Res; 1984 Mar; 295(1):121-6. PubMed ID: 6713170
[TBL] [Abstract][Full Text] [Related]
3. Pressor action and dipsogenicity induced by angiotensin II and III in rats.
Wright JW; Morseth SL; Abhold RH; Harding JW
Am J Physiol; 1985 Nov; 249(5 Pt 2):R514-21. PubMed ID: 4061676
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 125I-angiotensin III and 125I-angiotensin II binding to rat brain membranes.
Abhold RH; Hanesworth JM; Harding JW
J Neurochem; 1988 Mar; 50(3):831-8. PubMed ID: 3339357
[TBL] [Abstract][Full Text] [Related]
5. Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats.
Wright JW; Sullivan MJ; Quirk WS; Batt CM; Harding JW
J Hypertens Suppl; 1986 Dec; 4(6):S408-11. PubMed ID: 3475426
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin III-induced dipsogenic and pressor responses in rodents.
Wright JW; Morseth SL; LaCrosse E; Harding JW
Behav Neurosci; 1984 Aug; 98(4):640-51. PubMed ID: 6380522
[TBL] [Abstract][Full Text] [Related]
7. Drinking to intracerebroventricularly infused angiotensin II, III, and IV in the SHR.
Wright JW; Roberts KA; Harding JW
Peptides; 1988; 9(5):979-84. PubMed ID: 3244565
[TBL] [Abstract][Full Text] [Related]
8. Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats.
Wright JW; Quirk WS; Hanesworth JM; Harding JW
Brain Res; 1988 Feb; 441(1-2):215-20. PubMed ID: 3359232
[TBL] [Abstract][Full Text] [Related]
9. Effects of intracerebroventricular microinjection of angiotensin III on the cardiovascular activities in rabbits.
Yu CG; Wu ZY; Zhang SY; Yang K
J Tongji Med Univ; 1988; 8(2):98-100. PubMed ID: 3249347
[No Abstract] [Full Text] [Related]
10. Characterization of angiotensin binding in the African green monkey.
Petersen EP; Abhold RH; Camara CG; Wright JW; Harding JW
Brain Res; 1985 Aug; 341(1):139-46. PubMed ID: 4041782
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and biological activities of angiotensin II and des-Asp1-angiotensin II in isolated adrenal glomerulosa cells.
Aguilera G; Capponi A; Baukal A; Fujita K; Hauger R; Catt KJ
Endocrinology; 1979 May; 104(5):1279-85. PubMed ID: 436776
[No Abstract] [Full Text] [Related]
12. Intracerebroventricularly infused angiotensin II or III do not alter voluntary alcohol intake in rats.
Grupp LA; Harding S
Pharmacol Biochem Behav; 1995 Aug; 51(4):593-9. PubMed ID: 7675830
[TBL] [Abstract][Full Text] [Related]
13. Characterization of angiotensin binding to gerbil brain membranes using [125I]angiotensin III as the radioligand.
Petersen EP; Camara CG; Abhold RH; Wright JW; Harding JW
Brain Res; 1984 Nov; 321(2):225-35. PubMed ID: 6498516
[TBL] [Abstract][Full Text] [Related]
14. Roles of brain angiotensins II and III in thirst and sodium appetite.
Wilson WL; Roques BP; Llorens-Cortes C; Speth RC; Harding JW; Wright JW
Brain Res; 2005 Oct; 1060(1-2):108-17. PubMed ID: 16182260
[TBL] [Abstract][Full Text] [Related]
15. Aminopeptidase A antiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses.
Song L; Wilk S; Healy DP
Brain Res; 1997 Jan; 744(1):1-6. PubMed ID: 9030406
[TBL] [Abstract][Full Text] [Related]
16. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
Zini S; Fournie-Zaluski MC; Chauvel E; Roques BP; Corvol P; Llorens-Cortes C
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11968-73. PubMed ID: 8876246
[TBL] [Abstract][Full Text] [Related]
17. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
Abhold RH; Sullivan MJ; Wright JW; Harding JW
J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin (A I, A II, A III) receptor characterization. Correlation of prostaglandin release with peptide degradation.
Blumberg AL; Nishikawa K; Denny SE; Marshall GR; Needleman P
Circ Res; 1977 Aug; 41(2):154-8. PubMed ID: 194728
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.
Pendleton RG; Gessner G; Horner E
J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity labeling of the rat isolated portal vein: determination of affinity constants and "spare" receptors for angiotensins II and III.
Kwok YC; Moore GJ
J Pharmacol Exp Ther; 1984 Oct; 231(1):137-40. PubMed ID: 6092600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
